Atlas Trials

Familial Chylomicronemia Syndrome

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Familial Chylomicronemia Syndrome

RecordFirmDate
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRX) Administered to Adults With Familial Chylomicronemia Syndrome (FCS) Previously Treated With Volanesorsen (NCT05185843)Ionis Pharmaceuticals, Inc.2022-02-25
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Participants With Familial Chylomicronemia Syndrome (FCS) (NCT05130450)Ionis Pharmaceuticals, Inc.2021-11-18
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) Administered to Patients With Familial Chylomicronemia Syndrome (FCS) (NCT04568434)Ionis Pharmaceuticals, Inc.2020-11-18
InFocus France Epidemiological Study of Health Burden in Major Hypertriglyceridemia (NCT04223908)New French Society of Atherosclerosis2018-09-19
Medical Complications in Familial and Multifactorial Chylomicronaemia Syndromes (NCT03912181)Hospices Civils de Lyon2018-03-01
Phase 2 Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Chylomicronemia Syndrome (FCS) (NCT03360747)Akcea Therapeutics2017-12-21
The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Chylomicronemia Syndrome (NCT02658175)Akcea Therapeutics2015-12-23
The APPROACH Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome (NCT02211209)Ionis Pharmaceuticals, Inc.2014-12-01
Olezarsen Early Access Program for Patients With Familial Chylomicronemia Syndrome (FCS) (NCT06360237)Ionis Pharmaceuticals, Inc.

Track Familial Chylomicronemia Syndrome automatically

Every clearance here is in the API, with alerts when new ones post.